A Korean company developing a big data and artificial intelligence based non-invasive medical device for measuring blood glucose and blood pressure seeks foreign investors under financial agreement

CommercialJužná KóreaBOKR20210614001
Offers
Summary: 
A Korean company has been developing a non-invasive blood glucose and blood pressure medical device using a ballistocardiogram measuring sensor. This company is also employing technologies of artificial intelligence and big data analysis to the developed medical device to increase data accuracy and prediction of personal health information. In order to do this, the company is looking for foreign investors under financial agreement.
Description: 
According to healthcare market research reports, as the number of patients with diabetes and hypertension continuously increases, the pertinent measurement device market is growing very fast. To meet this demand, there are various personal medical devices to measure blood glucose and blood pressure in the market, including invasive glucose meter, aneroid type blood pressure monitors, and forearm or wrist type electronic blood pressure monitors. However, several disadvantages are existed in terms of convenience, safety and accuracy such as using needles to draw blood and storing the blood or adhering sensors to a person's skin. To solve these problems and meet patients’ demand for accurate and safe medical device, a Korean company, which has proficiency in AI (artificial intelligence) based healthcare solutions, has been developing a non-invasive blood glucose and blood pressure measurement medical device using a bllistocardiogram sensor. The device measures biometric factors immediately upon placing their wrist on the device. With this needle-free device, users can easily measure actual heart pumping signals and estimate the physiological parameters such as heart rate, respiratory rate, heart rate variability and cardiac output. The company already applied for patent on this technology and has concrete business plan including business roadmap, domestic & overseas marketing plan. The company is looking for foreign investors under financial agreement in order to further develop product, certify, and do clinical trial.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
The company is interested in doing business with an international company willing to invest its product under financial agreement. Partners working in the healthcare/AI/ is considered as the priority but not a MUST. The partner can be an individual investor or a company interest in investing innovative medical device development. Ideally, the partner has its sales network of personal medical devices to actively find potential customers in partner’s region.
Technical Specification or Expertise Sought: 
3-axis excursion sensing and deep learning algorithm
Stage of Development: 
Prototype available for demonstration
Comments Regarding Stage of Development: 
Chosun University Hospital Algorithm Verification Results: MAE (Mean absolute error) Excellent
IPR Status: 
Patent(s) applied for but not yet granted
External code: 
BOKR20210614001